Intense Airway Eosinophilia in Asthma
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Eosinophilic Asthma
Related studies linked through entity extraction aliases.
Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe Asthma
- Status
- COMPLETED
- Phase
- N/A
Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
- Status
- COMPLETED
- Phase
- PHASE3
Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
- Status
- COMPLETED
- Phase
- PHASE3